Estrogen modulation of opioid and cholecystokinin systems in the limbic- hypothalamic circuit

Brain Research Bulletin

Volumn 44, Issue 4, 1997, Pages 335-343

  Micevych, Paul E ^a   Eckersell, Clair B ^a   Brecha, Nicholas ^a   Holland, Krista L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisense Oligodeoxynucleotides; Downregulation; Internalization; Opiate receptors; Stress

Indexed keywords

BETA ENDORPHIN; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; DYNORPHIN; ENKEPHALIN; ESTROGEN; ETORPHINE; MU OPIATE RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR;

ARTICLE; FEMALE; HORMONAL REGULATION; HYPOTHALAMUS; INTERNALIZATION; LIMBIC SYSTEM; LORDOSIS; MEDIAL PREOPTIC AREA; NONHUMAN; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SYNAPTIC TRANSMISSION;

ANIMALS; CHOLECYSTOKININ; ENKEPHALINS; FEMALE; HYPOTHALAMUS; LIMBIC SYSTEM; MALE; OLIGONUCLEOTIDES, ANTISENSE; POSTURE; RATS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, OPIOID; SEXUAL BEHAVIOR, ANIMAL; TRANSCRIPTION, GENETIC;

EID: 0030665771     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00212-8     Document Type: Article

References (96)

1. Adan R. A., Burbach J. P. Regulation of vasopressin and oxytocin gene expression by estrogen and thyroid hormone. Prog. Brain Res. 92:1992;127-136.
2. 125I-cholecystokinin octapeptide binding in the ventromedial hypothalamic nucleus. Neuroendocrinology. 45:1987;257-262.
3. Akesson T. R., Micevych P. E. Endogenous opioid-immunoreactive neurons of the ventromedial hypothalamic nucleus concentratre estrogen in male and female rats. J. Neurosci Res. 28:1991;359-366.
4. Akesson T. R., Micevych P. E. Evidence for an absence of estrogen concentration by CCK-immunoreactive neurons in the hypothalamus of the female rat. J. Neurobiol. 19:1988;3-16.
5. Allen D. L., Renner K. J., Luine V. N. Naltrexone facilitation of sexual receptivity in the rat. Horm. Behav. 19:1985;98-103.
6. Babcock A. M., Block G. J., Micevych P. E. Injections of cholecystokinin into the ventromedial hypothalamic nucleus inhibit lordosis behavior in the rat. Physiol. Behav. 43:1988;195-199.
7. Benoliel J. J., Bourgoin S., Mauborgne A., Legrand J. C., Hamon M., Cesselin F. Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation. Neurosci. Lett. 124:1991;204-207.
8. Caron M. G., Lefkowitz R. J. Catecholamine receptors Structure, function, and regulation . Recent Prog. Horm. Res. 48:1993;277-290.
9. Clarke G., Wood P., Merrick L., Lincoln D. W. Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones. Nature. 282:1979;746-748.
10. Dado R. J., Law P. Y., Loh H. H., Elde R. Immunofluorescent identification of a δ-opioid receptor on primary afferent nerve terminals. Neuroreport. 5:1993;341-344.
11. DeBold J. F., Frye C. A. Genomic and non-genomic actions of progesterone in the control of female hamster sexual behavior. Horm. Behav. 28:1994;445-453.
12. Dellovade T. L., Zhu Y. S., Pfaff D. W. Potential interactions between estrogen receptor and thyroid receptors relevant for neuroendocrine systems. J. Steroid Biochem. Mol. Biol. 53:1995;27-31.
13. Dornan W. A., Bloch G. J., Priest C. A., Micevych P. E. Microinjection of cholecystokinin into the medial preoptic nucleus facilitates lordosis behavior in the female rat. Physiol. Behav. 45:1989;969-974.
14. Dourish C. T., Hawley D., Iversen S. D. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. Eur. J. Pharmacol. 147:1988;469-472.
15. Drouva S.V., Laplante E., Gautron J.P., Kordon C. Effects of 17β-estradiol on LHRH release from rat mediobasal hypothalamic slices. Neuroendocrinology. 38:1985;152-157.
16. Dupont A., Barden N., Cusan L., Merand Y., Labrie F., Vaudry H. β-Endorphin and metenkephalins Their distribution, modulation by estrogens and haloperidol and role in neuroendocrine control . Fed. Proc. 39:1980;2544-2550.
17. Eckersell C. B., Micevych P. E. Opiate receptor modulation of estrogen-induced cholecystokinin and tachykinin mRNA but not enkephalin mRNA levels in the limbic system and hypothalamus. Neuroscience. 80:1997;473-485.
18. Eckersell C. B., Popper P., Micevych P. E. Stress up-regulates preproenkephalin (PPE) mRNA levels in the limbic system and hypothalamus of the female rat. Soc. Neurosci. Abstr. 22:1996;1415.
19. Eckersell C. B., Priest C. A., Micevych P.E. Temporal regulation of preproenkephalin-A mRNA expression by estrogen in the posterior dorsal medial amygdala of the female rat. Soc. Neurosci. Abstr. 20:1994;1770.
20. Elde R., Arvidsson U., Riedl M., Vulchanova L., Lee J. H., Dado R., Nakano A., Chakrabarti S., Zhang X., Loh H. H., et al. Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann. NY Acad. Sci. 757:1995;390-404.
21. Faris P. L., Beinfeld M. C., Scallet A. C., Johannessen J. N., Olney J. W. Increase in hypothalamic cholecystokinin following acute and chronic morphine. Brain Res. 367:1986;405-407.
22. Faris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
23. Felicio L. F., Mann P. E., Bridges R. S. Intracerebroventricular cholecystokinin infusions block β-endorphin-induced disruption of maternal behavior. Pharmacol. Biochem. Behav. 39:1991;201-204.
24. Glass C. K., Holloway J. M., Devary O. V., Rosenfeld M. G. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell. 54:1988;313-323.
25. Grady E. F., Garland A. M., Gamp P. D., Lovett M., Payan D. G., Bunnett N. W. Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol. Biol. Cell. 6:1995;509-524.
26. Hammer R. P., Brady L. S., Abelson L., Micevych P.E. Differential localization of opioid neurons projecting to the medial preoptic nucleus. Anat. Rec. 229:1991;35A.
27. Hammer R. P., Cheung S. Sex steroid regulation of hypothalamic opioid function. Micevych, P. 1995;143-159 Cambridge University Press, E.; Hammer, R. P.; eds. Neurobiological effects of sex steroid hormones. New York.
28. Han J. S., Ding X. Z., Fan S. G. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates? Neuropeptides. 5:1985;399-402.
29. Harrison N. L., Majewska M. D., Meyers D.E. R., Barker J. L. Rapid actions of steroids on CNS neurons. Lakoski, J. 1989;137-166 Liss, M., Perez-Polo J. R.; Rassin D. K.; eds. Neural control of reproductive function. New York.
30. Herbison A. E., Theodosis D. T. Localization of oestrogen receptors in preoptic neurons containing neurotensin but not tyrosine hydroxylase, cholecystokinin or luteinizing hormone-releasing hormone in the male and female rat. Neuroscience. 50:1992;283-298.
31. Hill R. G., Boden P. Electrophysiological actions of CCK in the mammalian central nervous system. Hughes, J. 1989;186-194 Ellis Horwood, Dockray G.; Woodruff G, eds. The neuropeptide cholecystokinin (CCK). New York.
32. Hill R. G., Hughes J., Pittaway K. M. Antinociceptive action of cholecystokinin octapeptide (CCK-8) and related peptides in rats and mice Effects of naloxone and peptidase inhibitors . Neuropharmacology. 26:1987;289-300.
33. Holland K. L., Abelson L., Micevych P. E. Estrogen stimulates cholecystokinin and preproenkephalin mRNA in the female limbic-hypothalamic circuit during the peripubertal period. Soc. Neurosci. Abstr. 22:1996;561.
34. Holland, K. L.; Popper, P.; Micevych, P. E. Antisense oligodeoxynucleotides to CCK-A receptor mRNA inhibit lordosis behavior. Physiol. Behav. (in press).
35. Honda T., Wada E., Battey J. F., Wank S. A. Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol. Cell. Neurosci. 4:1993;143-154.
36. Hoxie J. A., Ahuja M., Belmonte E., Pizarro S., Parton R., Brass L. F. Internalization and recycling of activated thrombin receptors. J. Biol. Chem. 268:1993;13756-13763.
37. Igwe O. J. Modulation of substance P-ergic system in the rat spinal cord by an opioid antagonist. Mol. Brain Res. 21:1994;263-273.
38. 3H]naloxone) binding are associated with the progesterone-induced luteinizing hormone surge. Endocrinology. 124:1989;199-206.
39. Jessell, T. M.; Iversen, L. L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268:549-151; 1977.
40. Keith D., Murray S., Zaki P., Chu P., Lisson D., Kang L., Aimi J., Evans C., von Zastrow M. Rapid endocytosis of opioid receptors Differential regulation by opioid peptide and morphine . Soc. Neurosci. Abstr. 21:1995;1353.
41. B-mediated hyperpolarization of hypothalamic arcuate neurons. J. Neurosci. 12:1992;2745-2750.
42. Lagrange A. H., Ronnekleiv O. K., Kelly M.J. Estradiol-17β and μ-opioid peptides rapidly hyperpolarize GnRH neurons A cellular mechanism of negative feedback? Endocrinology. 136:1995;2341-2344.
43. Lagrange A. H., Ronnekleiv O. K., Kelly M.J. The potency of μ-opioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17β-estradiol. J. Neurosci. 14:1994;6196-6204.
44. Li C. S., Kaba H., Saito H., Seto K. Cholecystokinin Critical role in mediating olfactory influences on reproduction . Neuroscience. 48:1992;707-713.
45. Lutz R. A., Pfister H. P. Opioid receptors and their pharmacological profiles. J. Recept. Res. 12:1992;267-286.
46. Mansour A., Fox C. A., Burke S., Meng F., Thompson R. C., Akil H., Watson S. J. μ, δ and κ delta opioid receptor mRNA expression in the rat CNS An in situ hybridization study . J. Comp. Neurol. 350:1994;412-438.
47. Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
48. Mansour A., Thompson R. C., Akil H., Watson S. Delta opioid receptor mRNA ditribution in the brain Comparison to δ receptor binding and proenkephalin mRNA . J. Chem. Neuroanat. 6:1993;351-362.
49. Mantyh P. W., Allen C. J., Ghilardi J. R., Rogers S. D., Mantyh C. R., Liu H., Basbaum A. I., Vigna S. R., Maggio J. E. Rapid endocytosis of a G protein-coupled receptor Substance P evoked internalization of its receptor in the rat striatum in vivo . Proc. Natl. Acad. Sci. USA. 92:1995;2622-2626.
50. Mantyh, P. W.; DeMaster, E.; Malhotra, A.; Ghilardi, J. R.; Rogers, S. D.; Mantyh, C. R.; Liu, H.; Basbaum, A. I.; Vigna, S. R.; Maggio, J.E.; et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 268:1629-1232; 1995.
51. Mateo A. R., Hijazi M., Hammer R. P. ; Jr. Dynamic patterns of medial preoptic μ-opiate receptor regulation by gonadal steroid hormones. Neuroendocrinology. 55:1992;51-58.
52. Micevych P. E. , Yaksh, T. L., Go, V. L. W. Opiate-mediated inhibition of the release of cholecystokinin and substance P, but not neurotensin from cat hypothalamic slices. Brain Res. 250:1982;283-289.
53. Micevych P. E., Abelson L., Fok H., Ulibarri C., Priest C.A. Gonadal steroid control of preprocholecystokinin mRNA expression in the limbic-hypothalamic circuit Comparison of adult with neonatal steroid treatments . J. Neurosci. Res. 38:1994;386-398.
54. Micevych P. E., Ableson L., Fok H., Ulibarri C., Priest C. A. Gonadal steroid control of preproenkephalin mRNA expression in the limbic-hypothalamic circuit Comparison of adult with neonatal steroid treatments . J. Neorosci. Res. 38:1994;386-398.
55. Micevych P. E., Akesson T., Elde R. Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat II . Bed nucleus of the stria terminalis and amygdala. J. Comp. Neurol. 269:1988;381-391.
56. Micevych, P. E.; Block, G. J. Estrogen regulation of a reproductively relevant cholecystokinin circuit in the hypothalamus and limbic system of the rat. In: Hughes, J.; Dockray, G.; Woodruff, G. eds. The neuropeptide cholecystokinin (CCK); New York: John Wiley; 1989:68-73.
57. Micevych P. E., Eckersell C. B., Holland K., Smith A. Induction of CCK mRNA levels in the limbic-hypothalamic circuit Time course and site-specitic effects of estrogen . J. Neurobion. 30:1996;465-479.
58. Micevych P. E., Hammer R. P. Neurobiological effects of sex steroid hormones. 1995;Cambridge University Press, Cambridge.
59. Micevych P. E., Matt D. W., Go V. L. Concentrations of cholecystokinin, substance P, and bombesin in discrete regions of male and female rat brain Sex differences and estrogen effects . Exp. Neurol. 100:1988;416-425.
60. Micevych P. E., Park S. S., Akesson T. R., Elde R. Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat I . Hypothalamus. J. Comp. Neurol. 255:1987;124-136.
61. Micevych P. E., Ulibarri C. Development of the limbic-hypoythalamic cholecystokinin circuit A model of sexual differentiation . Dev. Neurosci. 14:1992;11-34.
62. Micevych P. E., Yaksh T., Go V. L. W., Finklestein J. In vitro release of cholecystokinin from hypothalamus and frontal cortex of Sprague-Dawley, Zucker lean (Fa/-) and obese (fa/fa) rats. Peptides. 5:1982;73-80.
63. Micevych, P. E.; Yaksh, T. L.; Go, V. W.; Finkelstein, J. A. Effect of opiates on the release of cholecystokinin from in vitro hypothalamus and frontal cortex of Zucker lean (Fa/-) and obese (fa/fa) rats. Brain Res. 337:382-305; 1985.
64. Moran T. H. , Robinson, P. H., Goldrich, M. S.; McHugh, P. R. Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res. 362:1986;175-179.
65. Noble F., Derrien M., Roques B. P. Modulation of opioid antinociception by CCK at the supraspinal level Evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain . Br. J. Pharmacol. 109:1993;1064-1070.
66. O'Neill M. F., Dourish C. T., Iversen S. D. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK-antagonist MK-329. Neuropharmacology. 28:1989;243-247.
67. B antagonist in the rat. Neurosci. Lett. 181:1994;9-12.
68. Pfaff, D. W., Schwartz-Giblin, S., McCarthy, M.; Kow, L.-M. Cellular and molecular reproductive behaviors. In: Knobil E.; Neill J.D., eds. The physiology of Reproduction, vol. 2. New York: Raven Press, Ltd.; 1994:107-220.
69. Pfaff D. W., Modianus D. Neural mechanisms of female reproductive behaviors. N. 1985;423-480 Plenium Press, Alder, N.; Pfaff D. W.; Goy R. W. eds. Handbook of behavioral neurobiology, Vol. 7. Reproduction. New York.
70. Pfaff D. W., Zhu Y.-S., Dellovade T. L., Yen P., Chin W. W. Interactions of estrogen and thyroid hormone on the regulation of preproenkephalin (PPE) gene expression in the hypothalamus and striatum of female rats. Soc. Neurosci. Abstr. 21:1995;189.
71. Pfaus J. G., Pfaff D. W. μ,δ and κ-opioid receptor agonists selectively modulate sexual behaviors in the female rat Differential dependence on progesterone . Horm. Behav. 26:1992;457-473.
72. Popper P., Priest C. A., Micevych P. E. Effects of sex steroids on the cholecystokinin circuit modulating reproductive behavior. Micevych P. E., Hammer R. P. Neurobiological effects of sex steroid hormones. 1995;160-183 Cambridge University Press, New York.
73. Priest C. A., Borsook D., Pfaff D. W. Estrogen and stress interact to regulate the hypothalamic expression of a human proenkephalin promoter-β-galactosidase fusion gene in a site-specific and gender-specific manner. J. Neuroendocrinol. 9:1997;317-326.
74. Priest C. A., Eckersell C. B., Micevych P.E. Estrogen regulates preproenkephalin-A mRNA levels in the rat ventromedial nucleus Temporal and cellular aspects . Mol. Brain Res. 28:1995;251-262.
75. Pu S., Zhuang H., Lu Z., Wu X., Han J. Cholesystokinin gene expression in rat amygdaloid neurons Normal distribution and effect of morphine tolerance . Mol. Brain Res. 21:1994;183-189.
76. Romano G. J., Harlan R. E., Shiverst B. D., Howells R. D., Pfaff D. W. Estrogen increases proenkephalin messenger ribonucleic acid levels in the ventromedial hypothalamus of the rat. Mol. Endocrinol. 2:1988;1320-1328.
77. Romano G. J., Mobbs C. V., Howells R. D., Pfaff D. W. Estrogen regulation of proenkephalin gene expression in the ventromedial hypothalamus of the rat Temporal qualities and synergism with progesterone . Mol. Brain Res. 5:1989;51-58.
78. 3H]cholecystokinin in the ventromedial hypothalamus is modulated by an afferant brainstem projection but not by ovarian steroids. Brain Res. 564:1991;102-108.
79. Simon E. J. Opioid receptors and endogenous opioid peptides. Med. Res. Rev. 11:1991;357-374.
80. Sirinathsinghji D. J. S. Regulation of lordosis behavior in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area. Brain Res. 375:1986;149-156.
81. Sternini C., Spann M., Anton B., Keith D. E., Bunnett N. W., von Zastrow M., Evans C., Brecha N. Agonist selective endocytosis of μ-opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;9241-9246.
82. Suh H. H., Tseng L. F. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by β-endorphin and morphine administered intracerebroventricularly in mice. Eur. J. Pharmacol. 179:1990;329-338.
83. Tischkau S., Ramirez V. A specific membrane binding protein for progesterone in rat brain Sex differences and induction by estrogen . Proc. Natl. Acad. Sci. USA. 90:1993;1285-1289.
84. Trowbridge I. S., Collawn J. F., Hopkins C.R. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu. Rev. Cell Biol. 9:1993;129-161.
85. Ulibarri C., Micevych P. E. Role of perinatal estrogens in sexual differentiation of the inhibition of lordosis by exogenous cholecystokinin. Physiol. Behav. 54:1993;95-100.
86. von Zastrow M., Kobilka B. K. Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. Biol. Chem. 267:1992;3530-3538.
87. Wank S. A., Harkins R., Jensen R. T., Shapira H., Weerth De A.;, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Nat. Acad. Sci. USA. 89:1992;3125-3129.
88. Waterman M. L., Adler S., Nelson C., Greene G.L., Evans R. M., Rosenfeld M. G. A single domain of the estrogen receptor confers deoxyribonucleic acid binding and transcriptional activation of the rat prolactin gene. Mol. Endocrinol. 2:1988;14-21.
89. Watkins L. R., Kinscheck I. B., Kaufman E.F., Miller J., Frenk H., Mayer D. J. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res. 327:1985;181-190.
90. Wiesner J. B., Moss R. L. Behavioral specificity of beta-endorphin suppression of sexual behavior Differential receptor antagonism . Pharmacol. Biochem. Behav. 24:1986;1235-1239.
91. Wiesner J. B., Moss R. L. Suppression of receptive and proceptive behavior in ovariectomized, estrogen-progesterone-primed rats by intraventricular β-endorphin Studies of behavioral specificity . Neuroendocrinology. 43:1986;57-62.
92. Wilcox J. N., Roberts J. L. Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels. Endocrinology. 117:1985;2392-2396.
93. Wilkinson M., Brawer J. R., Wilkinson D. A. Gonadal steroid-induced modification ofopiate binding sites in anterior hypothalamus of female rats. Biol. Reprod. 32:1985;501-506.
94. Yaksh T. L. The central pharmacology of primary afferents and emphasis of the disposition and role of primary afferent substance P. Yaksh T. L. Spinal afferent processing. 1986;165-195 Plenium Press, New York.
95. Zaborsky L., Beinfield M. C., Palkovits M., Heimen L. Brainstem projection to the hypothalamic ventromedial nucleus in the rat A CCK-containing long ascending pathway . Brain Res. 303:1984;225-231.
96. Zhou Y., Sun Y.-H., Zhang Z.-W., Han J.-S. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of μ-opioid analgesia by CCK-B receptor antagonist L-365,260 in rat spinal cord. Euro. J. Pharmacol. 234:1993;147-154.